Balance Sheet Healthpeak Properties, Inc.

Equities

DOC

US42250P1030

Specialized REITs

Market Closed - Nyse Other stock markets 04:00:02 2025-12-05 pm EST			5-day change	1st Jan Change
17.02 ^USD	-0.93%		-6.79%	-16.03%

Nov. 24	Wells Fargo Adjusts Healthpeak Properties Price Target to $19 From $18, Maintains Equal Weight Rating	MT
Nov. 14	JPMorgan Adjusts Price Target on Healthpeak Properties to $18 From $20, Maintains Neutral Rating	MT

d1de85508faa720128a.Er6SwYPZw4FcWKftytejx1YJ0TjtruBSP1mQ6lmCIHk.ddWkm_nsoOAUMt7fgeLFi2QkhVW85a4iZSjCpR2vZVR5yv-pyJuL3iQX9g

Published financial data: HEALTHPEAK PROPERTIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Rental Revenues	1.18B	1.38B	1.54B	1.63B	2.09B
Tenant Reimbursements	-	-	-	-	-
Property Management Fee	-	-	-	-	-
Interest and Investment Income, Total (Revenue Block)	26.27M	46.48M	24.47M	21.78M	44.78M
Other Revenues, Total	436M	471M	495M	527M	568M
Total Revenues	1.64B	1.9B	2.06B	2.18B	2.7B
Property Expenses	795M	767M	860M	901M	1.07B
Selling General & Admin Expenses, Total	99.24M	106M	99.93M	103M	106M
Depreciation & Amortization - (IS) - (Collected)	554M	684M	711M	750M	1.06B
Provision For Loan Losses - (Ins. / REIT / Utility Templates)	-8.86M	-1.69M	-6.53M	-2.09M	-7.67M
Total Operating Expenses	1.46B	1.56B	1.68B	1.76B	2.24B
Operating Income (REIT / Utility Template)	188M	337M	384M	425M	460M
Interest Expense, Total	-218M	-158M	-173M	-200M	-280M
Net Interest Expenses	-218M	-158M	-173M	-200M	-280M
Income (Loss) on Equity Invest.	-66.6M	6.1M	1.98M	10.2M	-1.52M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	16.84M	3.81M	8.06M	3.39M	-18.2M
EBT, Excl. Unusual Items	-80.15M	189M	221M	239M	160M
Restructuring Charges	-	-	-7M	-	-
Total Merger & Related Restructuring Charges	-	-	-	-11M	-129M
Gain (Loss) on Sale of Investments	170M	-	-	-	77.55M
Gain (Loss) on Sale of Assets	132M	191M	9.08M	86.46M	179M
Asset Writedown	-34.05M	-21.47M	-470K	7.69M	-15.31M
Insurance Settlements	-	-	-	3M	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-36.74M	-223M	286M	418K	-
EBT, Incl. Unusual Items	151M	134M	509M	325M	272M
Income Tax Expense	-9.42M	-3.26M	-4.42M	-9.62M	4.35M
Earnings From Continuing Operations	161M	138M	514M	335M	267M
Earnings Of Discontinued Operations	267M	386M	2.88M	-	-
Net Income to Company	428M	523M	516M	335M	267M
Minority Interest	-14.39M	-17.85M	-15.98M	-28.75M	-24.16M
Net Income - (IS)	414M	506M	500M	306M	243M
Preferred Dividend and Other Adjustments	2.42M	3.27M	2.66M	1.72M	758K
Net Income to Common Incl Extra Items	411M	502M	498M	304M	242M
Net Income to Common Excl. Extra Items	144M	117M	495M	304M	242M
Per Share Items
Net EPS - Basic	0.77	0.93	0.92	0.56	0.36
Basic EPS - Continuing Operations	0.27	0.22	0.92	0.56	0.36
Basic Weighted Average Shares Outstanding	531M	539M	539M	547M	676M
Net EPS - Diluted	0.77	0.93	0.92	0.56	0.36
Diluted EPS - Continuing Operations	0.27	0.22	0.92	0.56	0.36
Diluted Weighted Average Shares Outstanding	531M	539M	539M	547M	676M
Normalized Basic EPS	-0.12	0.19	0.23	0.22	0.11
Normalized Diluted EPS	-0.12	0.19	0.23	0.22	0.11
Dividend Per Share	1.48	1.2	1.2	1.2	1.2
Payout Ratio	190.31	128.59	129.49	214.71	326.88
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	732M	1B	1.07B	1.15B	1.46B
EBITA	266M	422M	464M	501M	670M
EBIT	188M	337M	384M	425M	460M
EBITDAR	746M	1.02B	1.09B	1.17B	1.48B
Total Revenues (As Reported)	1.64B	1.9B	2.06B	2.18B	2.7B
Effective Tax Rate - (Ratio)	-6.24	-2.43	-0.87	-2.96	1.6
Current Domestic Taxes	-7.73M	1.13M	1.32M	4.99M	6.04M
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	-7.73M	1.13M	1.32M	4.99M	6.04M
Deferred Domestic Taxes	-1.69M	-4.39M	-5.75M	-14.6M	-1.69M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-1.69M	-4.39M	-5.75M	-14.6M	-1.69M
Normalized Net Income	-64.49M	100M	122M	120M	75.66M
Interest Capitalized	27.04M	24.08M	41.05M	56.85M	69.26M
Supplemental Operating Expense Items
Advertising Expense	6M	8M	7.9M	8M	9M
Selling and Marketing Expenses	6M	8M	7.9M	8M	9M
General and Administrative Expenses	93.24M	98.3M	92.03M	95.13M	97.16M
Net Rental Expense, Total	13.6M	14.44M	16.69M	17.01M	22.77M
Imputed Operating Lease Interest Expense	4.23M	3.27M	4.37M	5.08M	7.91M
Imputed Operating Lease Depreciation	9.37M	11.17M	12.32M	11.93M	14.86M
Maintenance & Repair Expenses, Total	-	-	-	-	110M
Stock-Based Comp., COGS (Total)	-	-	-	-	16.22M
Stock-Based Comp., G&A Exp. (Total)	-	-	28M	15M	16M
Stock-Based Comp., Other (Total)	21M	23M	-	-	-
Total Stock-Based Compensation	21M	23M	28M	15M	32.22M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Gross Property Plant And Equipment	13.72B	15.74B	16.45B	16.86B	20.34B
Accumulated Depreciation	-2.41B	-2.84B	-3.19B	-3.59B	-4.08B
Net Property Plant And Equipment	11.31B	12.9B	13.26B	13.27B	16.26B
Total Real Estate Assets	11.31B	12.9B	13.26B	13.27B	16.26B
Cash And Equivalents	44.23M	158M	72.03M	118M	120M
Accounts Receivable, Total	86.98M	93.4M	53.44M	55.82M	415M
Other Receivables	-	-	-	-	-
Investment In Debt and Equity Securities	-	36.1M	36.87M	14.98M	15.82M
Goodwill	-	-	-	18M	68.53M
Other Intangibles, Total	520M	520M	418M	314M	817M
Notes Receivable (Collected)	195M	416M	375M	218M	717M
Restricted Cash	67.21M	53.45M	54.8M	51.39M	64.49M
Other Current Assets, Total	2.63B	37.19M	49.87M	118M	7.84M
Trading Asset Securities, Total	-	397K	-	21.36M	35.12M
Deferred Tax Assets Long-Term (Collected)	87.19M	92.98M	98.98M	114M	115M
Deferred Charges Long-Term	-	-	-	-	222M
Other Long-Term Assets, Total	981M	949M	1.35B	1.39B	1.08B
Total Assets	15.92B	15.26B	15.77B	15.7B	19.94B
Liabilities
Current Portion of Long-Term Debt	13.02M	5.05M	90.09M	7.02M	807M
Current Portion of Leases	11.11M	16.03M	17.15M	16.95M	21.51M
Short-Term Borrowings	130M	-	-	-	-
Long-Term Debt	6.16B	6.16B	6.41B	6.87B	7.91B
Long-Term Leases	169M	189M	191M	190M	286M
Accounts Payable, Total	272M	228M	266M	240M	276M
Accrued Expenses, Total	78.74M	59.34M	59.29M	59.49M	76.04M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	416M	15.06M	4.07M	729K	-
Unearned Revenue Non Current	774M	789M	844M	906M	940M
Other Non Current Liabilities	557M	646M	604M	485M	565M
Total Liabilities	8.58B	8.11B	8.48B	8.77B	10.88B
Common Stock, Total	538M	539M	547M	547M	699M
Additional Paid In Capital	10.23B	10.1B	10.35B	10.41B	12.85B
Distributions In Excess Of Earnings	-3.98B	-4.12B	-4.27B	-4.62B	-5.17B
Comprehensive Income and Other	-3.68M	-3.15M	28.13M	19.37M	28.82M
Total Common Equity	6.79B	6.52B	6.65B	6.35B	8.4B
Minority Interest	556M	631M	634M	574M	656M
Total Equity	7.34B	7.15B	7.29B	6.92B	9.06B
Total Liabilities And Equity	15.92B	15.26B	15.77B	15.7B	19.94B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	539M	539M	547M	547M	700M
ECS Total Common Shares Outstanding	538M	539M	547M	547M	699M
Book Value / Share	12.61	12.09	12.17	11.61	12.01
Tangible Book Value	6.27B	6B	6.24B	6.02B	7.52B
Tangible Book Value Per Share	11.64	11.12	11.41	11	10.74
Total Debt	6.48B	6.37B	6.71B	7.08B	9.02B
Net Debt	6.43B	6.22B	6.63B	6.94B	8.87B
Debt Equivalent Oper. Leases	109M	116M	134M	136M	182M
Minority Interest, Total (Incl. Fin. Div)	556M	631M	634M	574M	656M
Equity Method Investments, Total	403M	404M	707M	783M	937M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	1.87B	2.6B	2.67B	2.65B	2.92B
Buildings, Total	11.05B	12.03B	12.78B	13.33B	16.12B
Full Time Employees	217	196	199	193	387
Accumulated Allowance for Doubtful Accounts (Supple)	3.99M	1.87M	2.4M	2.28M	2.24M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	414M	506M	500M	306M	243M
Depreciation, Depletion & Amortization	467M	580M	609M	651M	786M
Amortization of Goodwill and Intangible Assets - (CF)	77.58M	85.51M	80.24M	75.24M	210M
Total Depreciation, Depletion & Amortization	544M	666M	689M	726M	996M
Amortization of Deferred Charges, Total	10.16M	9.22M	10.88M	11.92M	28.97M
(Gain) Loss On Sale of Asset - (CF)	-592M	-605M	-33.12M	-86.46M	-179M
(Gain) Loss on Sale of Investments - (CF)	-160M	-1.04M	-311M	-234K	-77.55M
Total Asset Writedown	244M	54.21M	470K	-7.69M	15.31M
Provision for Credit Losses	-	1.69M	6.53M	2.09M	7.67M
(Income) Loss On Equity Investments - (CF)	80.08M	-6.26M	-1.11M	-9.29M	13.52M
Stock-Based Compensation (CF)	17.37M	18.2M	26.46M	14.48M	15.54M
Change in Accounts Receivable	15.28M	18.63M	-17.43M	-21.57M	-40.86M
Change in Accounts Payable	93.5M	7.77M	136M	105M	85.64M
Change in Other Net Operating Assets (Collected)	-	-	-	-	-
Other Operating Activities	-51.06M	127M	-107M	-83.4M	-38.5M
Net Cash From Discontinued Operations	143M	-	-	-	-
Cash from Operations	758M	795M	900M	956M	1.07B
Acquisition of Real Estate Assets, Total	-2.06B	-2.21B	-1.15B	-861M	-720M
Sale of Real Estate Assets, Total	1.3B	2.4B	47.88M	142M	649M
Net Sale / Acquisition of Real Estate Assets	-752M	194M	-1.1B	-719M	-71.52M
Cash Acquisitions	-394M	-	-	-	-179M
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	182M	12.38M	117M	-67.75M	86.97M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-45.56M	325M	105M	185M	41.26M
Other Investing Activities, Total	1.8M	-	1.45M	24.98M	8.71M
Cash from Investing	-1.01B	531M	-876M	-577M	-114M
Short Term Debt Issued, Total	4.74B	16.82B	-	-	-
Long-Term Debt Issued, Total	595M	1.09B	16.38B	11.09B	4.49B
Total Debt Issued	5.34B	17.91B	16.38B	11.09B	4.49B
Short Term Debt Repaid, Total	-4.71B	-15.79B	-	-	-
Long-Term Debt Repaid, Total	-568M	-2.43B	-16.06B	-10.71B	-4.34B
Total Debt Repaid	-5.27B	-18.21B	-16.06B	-10.71B	-4.34B
Issuance of Common Stock	1.07B	5.04M	308M	278K	317K
Repurchase of Common Stock	-10.53M	-12.84M	-67.84M	-6.52M	-191M
Common Dividends Paid	-787M	-650M	-648M	-657M	-795M
Common & Preferred Stock Dividends Paid	-787M	-650M	-648M	-657M	-795M
Other Financing Activities, Total	-87.82M	-330M	-33.33M	-52.12M	-109M
Cash from Financing	246M	-1.29B	-117M	-337M	-941M
Foreign Exchange Rate Adjustments	-153K	-	-	-	-
Net Change in Cash	-2.97M	37.76M	-92.61M	42.19M	15.28M
Supplemental Items
Cash Interest Paid	210M	173M	162M	188M	249M
Cash Income Tax Paid (Refund)	-786K	4.52M	-1.9M	1.92M	7.86M
Net Debt Issued / Repaid	63M	-301M	325M	378M	153M
Levered Free Cash Flow	1.58B	2.72B	954M	954M	771M
Unlevered Free Cash Flow	1.71B	2.81B	1.05B	1.07B	917M
Change In Net Working Capital	-1.03B	-1.91B	-93.84M	-60.81M	399M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	0.78	1.35	1.55	1.69	1.61
Return on Total Capital	0.88	1.54	1.75	1.9	1.79
Return On Equity %	2.29	1.9	7.12	4.71	3.34
Return on Common Equity	2.23	1.76	7.52	4.68	3.29
Margin Analysis
Gross Profit Margin %	51.14	59.45	57.96	58.61	60.11
SG&A Margin	6.03	5.61	4.85	4.73	3.93
EBITDA Margin %	44.51	52.87	52.06	52.78	53.92
EBITA Margin %	16.14	22.27	22.53	22.95	24.82
EBIT Margin %	11.43	17.76	18.64	19.5	17.03
Income From Continuing Operations Margin %	9.76	7.26	24.91	15.35	9.9
Net Income Margin %	25.14	26.66	24.28	14.03	9
Net Avail. For Common Margin %	8.74	6.15	24.01	13.95	8.98
Normalized Net Income Margin	-3.92	5.28	5.94	5.52	2.8
Levered Free Cash Flow Margin	96.32	143.66	46.27	43.75	28.53
Unlevered Free Cash Flow Margin	104	148.38	50.98	48.95	33.95
Asset Turnover
Asset Turnover	0.11	0.12	0.13	0.14	0.15
Fixed Assets Turnover	0.17	0.16	0.16	0.16	0.18
Receivables Turnover (Average Receivables)	10.92	15.28	21	29.87	5.35
Short Term Liquidity
Current Ratio	3.28	2.35	1.39	1.8	1.15
Quick Ratio	0.14	0.78	0.29	0.6	0.48
Operating Cash Flow to Current Liabilities	0.82	2.46	2.06	2.95	0.91
Days Sales Outstanding (Average Receivables)	33.5	23.88	17.38	12.22	68.44
Average Days Payable Outstanding	123.51	117.93	103.89	102.27	87.7
Long Term Solvency
Total Debt/Equity	88.2	89.2	92.01	102.28	99.62
Total Debt / Total Capital	46.86	47.15	47.92	50.56	49.9
LT Debt/Equity	86.11	88.91	90.54	101.94	90.47
Long-Term Debt / Total Capital	45.75	46.99	47.15	50.39	45.32
Total Liabilities / Total Assets	53.87	53.16	53.79	55.89	54.57
EBIT / Interest Expense	0.86	2.13	2.22	2.12	1.64
EBITDA / Interest Expense	3.42	6.44	6.3	5.83	5.27
(EBITDA - Capex) / Interest Expense	3.42	6.44	6.3	5.83	5.27
Total Debt / EBITDA	8.69	6.27	6.15	6.06	6.1
Net Debt / EBITDA	8.63	6.11	6.09	5.94	6
Total Debt / (EBITDA - Capex)	8.69	6.27	6.15	6.06	6.1
Net Debt / (EBITDA - Capex)	8.63	6.11	6.09	5.94	6
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.61	15.28	8.7	5.81	23.82
Gross Profit, 1 Yr. Growth %	0.96	35.38	5.97	7	26.98
EBITDA, 1 Yr. Growth %	-0.63	38.5	7.05	7.27	26.49
EBITA, 1 Yr. Growth %	-23.36	64.23	9.98	7.77	33.88
EBIT, 1 Yr. Growth %	-38.57	87.57	14.08	10.7	8.13
Earnings From Cont. Operations, 1 Yr. Growth %	-8.53	-14.19	272.87	-34.81	-20.15
Net Income, 1 Yr. Growth %	808.33	22.24	-1.01	-38.85	-20.54
Diluted EPS Before Extra, 1 Yr. Growth %	-17.62	-19.86	324.52	-39.44	-35.54
Normalized Net Income, 1 Yr. Growth %	-311.39	-243.55	21.43	8.16	-38.1
Net Property, Plant and Equip., 1 Yr. Growth %	34.7	14.05	2.79	0.06	22.51
Accounts Receivable, 1 Yr. Growth %	-32.81	7.38	-42.79	4.46	13.39
Total Assets, 1 Yr. Growth %	13.45	-4.16	3.37	-0.46	27
Common Equity, 1 Yr. Growth %	11.56	-3.24	2.14	-4.57	32.29
Tangible Book Value, 1 Yr. Growth %	7.62	-3.51	4.02	-3.22	24.88
Cash From Operations, 1 Yr. Growth %	-10.36	4.85	13.2	6.22	11.95
Levered Free Cash Flow, 1 Yr. Growth %	-173.64	72.8	-64.95	0.06	19.6
Unlevered Free Cash Flow, 1 Yr. Growth %	-184.42	65.24	-62.61	1.58	21.03
Dividend Per Share, 1 Yr. Growth %	0	-18.92	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.5	23.64	11.94	7.25	14.46
Gross Profit, 2 Yr. CAGR %	1.81	16.33	18.56	6.41	16.24
EBITDA, 2 Yr. CAGR %	1.16	16.72	20.34	7.07	16.08
EBITA, 2 Yr. CAGR %	-12.99	10.56	30.1	8.65	19.16
EBIT, 2 Yr. CAGR %	-22.4	5.09	39.72	12.1	8.35
Earnings From Cont. Operations, 2 Yr. CAGR %	-56.21	-11.4	78.87	55.9	-27.85
Net Income, 2 Yr. CAGR %	-37.57	233.22	10	-22.2	-30.3
Diluted EPS Before Extra, 2 Yr. CAGR %	-60.69	-18.75	84.44	60.34	-37.52
Normalized Net Income, 2 Yr. CAGR %	86.36	70.98	76.73	7.43	-18.12
Net Property, Plant and Equip., 2 Yr. CAGR %	5.26	23.95	8.27	1.41	10.72
Accounts Receivable, 2 Yr. CAGR %	-66.22	-15.06	-21.62	-22.69	178.62
Total Assets, 2 Yr. CAGR %	11.88	4.27	-0.47	1.44	12.44
Common Equity, 2 Yr. CAGR %	6.86	3.48	-0.59	-1.27	12.36
Tangible Book Value, 2 Yr. CAGR %	5.43	1.46	0.18	0.19	9.93
Cash From Operations, 2 Yr. CAGR %	-5.47	-3.05	8.95	9.66	9.05
Levered Free Cash Flow, 2 Yr. CAGR %	25.65	12.5	-22.44	-40.79	-10.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	21.74	17.81	-21.64	-38.38	-6.81
Dividend Per Share, 2 Yr. CAGR %	0	-9.96	-9.96	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-3.81	16.76	18.45	9.86	12.51
Gross Profit, 3 Yr. CAGR %	-6.53	11.58	12.77	14.57	12.86
EBITDA, 3 Yr. CAGR %	-8.04	11.9	13.4	15.82	13.19
EBITA, 3 Yr. CAGR %	-18.04	6.38	10.37	22.19	16.48
EBIT, 3 Yr. CAGR %	-22.75	2.57	8	29.29	10.76
Earnings From Cont. Operations, 3 Yr. CAGR %	-27.58	-45.21	43.04	27.76	24.74
Net Income, 3 Yr. CAGR %	-0.05	-21.9	122.34	-9.55	-21.65
Diluted EPS Before Extra, 3 Yr. CAGR %	-32.55	-50.16	40.99	27.24	18.34
Normalized Net Income, 3 Yr. CAGR %	4.7	75.34	52.88	45.38	-10.14
Net Property, Plant and Equip., 3 Yr. CAGR %	1.77	8.11	16.45	5.46	8.01
Accounts Receivable, 3 Yr. CAGR %	-51.34	-50.33	-25.54	-13.74	64.38
Total Assets, 3 Yr. CAGR %	4.16	6.25	3.97	-0.47	9.33
Common Equity, 3 Yr. CAGR %	8.59	3.1	3.03	-1.93	8.84
Tangible Book Value, 3 Yr. CAGR %	8.62	2.06	2.3	-1.06	7.82
Cash From Operations, 3 Yr. CAGR %	-3.62	-2.15	2.09	8.03	10.41
Levered Free Cash Flow, 3 Yr. CAGR %	-1.73	39.49	-23.76	-15.56	-34.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	-2.53	34.58	-19.67	-14.56	-31.17
Dividend Per Share, 3 Yr. CAGR %	0	-6.75	-6.75	-6.75	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.25	-2.29	2.2	12.86	16.84
Gross Profit, 5 Yr. CAGR %	-8.37	-3.98	3.01	9.51	14.27
EBITDA, 5 Yr. CAGR %	-9.46	-4.79	2.65	9.98	14.63
EBITA, 5 Yr. CAGR %	-19.25	-11.94	-0.75	7.37	14.17
EBIT, 5 Yr. CAGR %	-23.16	-14.01	-1.18	6.38	8.56
Earnings From Cont. Operations, 5 Yr. CAGR %	1.01	-18.12	3.97	-16.75	8.78
Net Income, 5 Yr. CAGR %	-5.86	-4.24	3.86	-22.02	39.8
Diluted EPS Before Extra, 5 Yr. CAGR %	-2.04	-22.42	0.86	-20.46	1.82
Normalized Net Income, 5 Yr. CAGR %	-14.39	-8.56	16.84	45.33	17.18
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.93	2.64	4.32	5.38	14.12
Accounts Receivable, 5 Yr. CAGR %	-40.5	-34.88	-41.12	-40.71	26.23
Total Assets, 5 Yr. CAGR %	-5.79	-0.64	2.28	4.3	7.28
Common Equity, 5 Yr. CAGR %	-6.19	3.27	4.65	1.33	6.66
Tangible Book Value, 5 Yr. CAGR %	-6.37	3.42	4.98	1.31	5.23
Cash From Operations, 5 Yr. CAGR %	-9.01	-8.11	1.23	2.41	4.82
Levered Free Cash Flow, 5 Yr. CAGR %	-1.9	-14	-10.6	-1	-18.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	-3.3	-14.23	-10.67	-1.55	-14.67
Dividend Per Share, 5 Yr. CAGR %	-8.12	-10.55	-4.11	-4.11	-4.11